Clinical issues related to the costs of alcoholism

Matthew O. Howard, Robert W. McGuffin, Andrew J. Saxon, Kevin L. Sloan, Roger (Dale) Walker

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Alcohol (ethanol) use disorders are prevalent in many countries and are associated with significant social and health costs. Little is known, however, about the comparative cost effectiveness of treatments for alcoholism. Pharmacoeconomic evaluations are largely (if not wholly) absent from the alcoholism treatment outcome database. We discuss pharmacological approaches to the treatment of alcohol withdrawal and dependence, describing agents that ameliorate withdrawal symptoms, deter alcohol consumption, reduce alcohol craving and produce conditioned alcohol aversion. Cost-relevant clinical considerations are elucidated and recommendations for cost-conscious pharmacological treatment of alcohol dependence are proffered.

Original languageEnglish (US)
Pages (from-to)134-145
Number of pages12
JournalPharmacoEconomics
Volume9
Issue number2
StatePublished - 1996

Fingerprint

Alcoholism
Costs and Cost Analysis
Alcohols
Pharmacology
Pharmaceutical Economics
Substance Withdrawal Syndrome
Alcohol Drinking
Health Care Costs
Cost-Benefit Analysis
Ethanol
Databases

ASJC Scopus subject areas

  • Pharmacology
  • Medicine (miscellaneous)

Cite this

Howard, M. O., McGuffin, R. W., Saxon, A. J., Sloan, K. L., & Walker, R. D. (1996). Clinical issues related to the costs of alcoholism. PharmacoEconomics, 9(2), 134-145.

Clinical issues related to the costs of alcoholism. / Howard, Matthew O.; McGuffin, Robert W.; Saxon, Andrew J.; Sloan, Kevin L.; Walker, Roger (Dale).

In: PharmacoEconomics, Vol. 9, No. 2, 1996, p. 134-145.

Research output: Contribution to journalArticle

Howard, MO, McGuffin, RW, Saxon, AJ, Sloan, KL & Walker, RD 1996, 'Clinical issues related to the costs of alcoholism', PharmacoEconomics, vol. 9, no. 2, pp. 134-145.
Howard MO, McGuffin RW, Saxon AJ, Sloan KL, Walker RD. Clinical issues related to the costs of alcoholism. PharmacoEconomics. 1996;9(2):134-145.
Howard, Matthew O. ; McGuffin, Robert W. ; Saxon, Andrew J. ; Sloan, Kevin L. ; Walker, Roger (Dale). / Clinical issues related to the costs of alcoholism. In: PharmacoEconomics. 1996 ; Vol. 9, No. 2. pp. 134-145.
@article{d893bc8d6c704c4bb20436398aee48d2,
title = "Clinical issues related to the costs of alcoholism",
abstract = "Alcohol (ethanol) use disorders are prevalent in many countries and are associated with significant social and health costs. Little is known, however, about the comparative cost effectiveness of treatments for alcoholism. Pharmacoeconomic evaluations are largely (if not wholly) absent from the alcoholism treatment outcome database. We discuss pharmacological approaches to the treatment of alcohol withdrawal and dependence, describing agents that ameliorate withdrawal symptoms, deter alcohol consumption, reduce alcohol craving and produce conditioned alcohol aversion. Cost-relevant clinical considerations are elucidated and recommendations for cost-conscious pharmacological treatment of alcohol dependence are proffered.",
author = "Howard, {Matthew O.} and McGuffin, {Robert W.} and Saxon, {Andrew J.} and Sloan, {Kevin L.} and Walker, {Roger (Dale)}",
year = "1996",
language = "English (US)",
volume = "9",
pages = "134--145",
journal = "PharmacoEconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "2",

}

TY - JOUR

T1 - Clinical issues related to the costs of alcoholism

AU - Howard, Matthew O.

AU - McGuffin, Robert W.

AU - Saxon, Andrew J.

AU - Sloan, Kevin L.

AU - Walker, Roger (Dale)

PY - 1996

Y1 - 1996

N2 - Alcohol (ethanol) use disorders are prevalent in many countries and are associated with significant social and health costs. Little is known, however, about the comparative cost effectiveness of treatments for alcoholism. Pharmacoeconomic evaluations are largely (if not wholly) absent from the alcoholism treatment outcome database. We discuss pharmacological approaches to the treatment of alcohol withdrawal and dependence, describing agents that ameliorate withdrawal symptoms, deter alcohol consumption, reduce alcohol craving and produce conditioned alcohol aversion. Cost-relevant clinical considerations are elucidated and recommendations for cost-conscious pharmacological treatment of alcohol dependence are proffered.

AB - Alcohol (ethanol) use disorders are prevalent in many countries and are associated with significant social and health costs. Little is known, however, about the comparative cost effectiveness of treatments for alcoholism. Pharmacoeconomic evaluations are largely (if not wholly) absent from the alcoholism treatment outcome database. We discuss pharmacological approaches to the treatment of alcohol withdrawal and dependence, describing agents that ameliorate withdrawal symptoms, deter alcohol consumption, reduce alcohol craving and produce conditioned alcohol aversion. Cost-relevant clinical considerations are elucidated and recommendations for cost-conscious pharmacological treatment of alcohol dependence are proffered.

UR - http://www.scopus.com/inward/record.url?scp=0030034701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030034701&partnerID=8YFLogxK

M3 - Article

C2 - 10160092

AN - SCOPUS:0030034701

VL - 9

SP - 134

EP - 145

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

IS - 2

ER -